Nationwide Review of the Administration and Oversight of Physician-Administered Drugs
States are required to collect rebates on covered outpatient drugs administered by physicians in order to be eligible for Federal matching funds (SSA § 1927(a)). Previous OIG work identified significant concerns with States' efforts in obtaining rebates for these physician-administered drugs. We will summarize the results and issues identified in these audits and examine CMS's policies and procedures to ensure States appropriately collect Medicaid rebates on physician-administered drugs.
|Announced or Revised||Agency||Title||Component||Report Number(s)||Expected Issue Date (FY)|
|October 2020||Centers for Medicare and Medicaid Services||Nationwide Review of the Administration and Oversight of Physician-Administered Drugs||Office of Audit Services||W-00-20-35860||2021|